Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men

Journal of Nutritional Biochemistry

Volumn 23, Issue 6, 2012, Pages 616-621

  Dawson, Kevin ^a   Zhao, Ling ^a,c   Adkins, Yuriko ^a   Vemuri, Madhuri ^a   Rodriguez, Raymond L ^a   Gregg, Jeffrey P ^b   Kelley, Darshan S ^a   Hwang, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Cardiovascular disease; Cathepsin L1; Docosahexaenoic acid; Gene expression; Inflammation; LDL receptor; Oxidized LDL receptor

Indexed keywords

CATHEPSIN L; DOCOSAHEXAENOIC ACID; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNITY; INFLAMMATION; MALE; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VITAMIN SUPPLEMENTATION;

ANTI-INFLAMMATORY AGENTS; CATHEPSIN L; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; HUMANS; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LDL; SCAVENGER RECEPTORS, CLASS E; UP-REGULATION;

EID: 84860889282     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.03.004     Document Type: Article

References (41)

1. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115(5):1111-1119.
2. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867.
3. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
4. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 2009, 33(1):54-66.
5. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124(4):783-801.
6. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006, 18(1):3-9.
7. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001, 276(20):16683-16689.
8. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., Lee W.H., Fitzgerald K.A., Hwang D.H. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004, 279(17):16971-16979.
9. Lee J.Y., Zhao L., Hwang D.H. Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr Rev 2010, 68(1):38-61.
10. Lee J.H., O'Keefe J.H., Lavie C.J., Harris W.S. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol 2009, 6(12):753-758.
11. Calzolari I., Fumagalli S., Marchionni N., Di Bari M. Polyunsaturated fatty acids and cardiovascular disease. Curr Pharm Des 2009, 15(36):4094-4102.
12. Calder P.C., Grimble R.F. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 2002, 56(Suppl 3):S14-S19.
13. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 Suppl):1505S-1519S.
14. Lopez-Garcia E., Schulze M.B., Manson J.E., Meigs J.B., Albert C.M., Rifai N., Willett W.C., Hu F.B. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004, 134(7):1806-1811.
15. Niu K., Hozawa A., Kuriyama S., Ohmori-Matsuda K., Shimazu T., Nakaya N., Fujita K., Tsuji I., Nagatomi R. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 2006, 84(1):223-229.
16. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Willett W.C., Rimm E.B. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108(2):155-160.
17. Zampelas A., Panagiotakos D.B., Pitsavos C., Das U.N., Chrysohoou C., Skoumas Y., Stefanadis C. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol 2005, 46(1):120-124.
18. Ciubotaru I., Lee Y.S., Wander R.C. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003, 14(9):513-521.
19. Sundrarjun T., Komindr S., Archararit N., Dahlan W., Puchaiwatananon O., Angthararak S., Udomsuppayakul U., Chuncharunee S. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J Int Med Res 2004, 32(5):443-454.
20. Tsitouras P.D., Gucciardo F., Salbe A.D., Heward C., Harman S.M. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 2008, 40(3):199-205.
21. Verlengia R., Gorjao R., Kanunfre C.C., Bordin S., de Lima T.M., Martins E.F., Newsholme P., Curi R. Effects of EPA and DHA on proliferation, cytokine production, and gene expression in Raji cells. Lipids 2004, 39(9):857-864.
22. Verlengia R., Gorjao R., Kanunfre C.C., Bordin S., Martins De Lima T., Martins E.F., Curi R. Comparative effects of eicosapentaenoic acid and docosahexaenoic acid on proliferation, cytokine production, and pleiotropic gene expression in Jurkat cells. J Nutr Biochem 2004, 15(11):657-665.
23. Calder P.C. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003, 38(4):343-352.
24. Kelley D.S., Taylor P.C., Nelson G.J., Mackey B.E. Dietary docosahexaenoic acid and immunocompetence in young healthy men. Lipids 1998, 33(6):559-566.
25. Kelley D.S., Siegel D., Fedor D.M., Adkins Y., Mackey B.E. DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009, 139(3):495-501.
26. Kelley D.S., Siegel D., Vemuri M., Chung G.H., Mackey B.E. Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men. J Nutr 2008, 138(1):30-35.
27. Kelley D.S., Siegel D., Vemuri M., Mackey B.E. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007, 86(2):324-333.
28. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., Soudais C., Dupuis S., Feinberg J., Fieschi C., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299(5615):2076-2079.
29. Oort P.J., Warden C.H., Baumann T.K., Knotts T.A., Adams S.H. Characterization of Tusc5, an adipocyte gene co-expressed in peripheral neurons. Mol Cell Endocrinol 2007, 276(1-2):24-35.
30. Wurfel M.M., Park W.Y., Radella F., Ruzinski J., Sandstrom A., Strout J., Bumgarner R.E., Martin T.R. Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. J Immunol 2005, 175(4):2570-2578.
31. Bouwens M., van de Rest O., Dellschaft N., Bromhaar M.G., de Groot L.C., Geleijnse J.M., Muller M., Afman L.A. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009, 90(2):415-424.
32. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997, 386(6620):73-77.
33. Ogura S., Kakino A., Sato Y., Fujita Y., Iwamoto S., Otsui K., Yoshimoto R., Sawamura T. Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ J 2009, 73(11):1993-1999.
34. Kataoka H., Kume N., Miyamoto S., Minami M., Moriwaki H., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999, 99(24):3110-3117.
35. Ishiyama J., Taguchi R., Yamamoto A., Murakami K. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells. Atherosclerosis 2010, 209(1):118-124.
36. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232(4746):34-47.
37. Anderson R.G., Goldstein J.L., Brown M.S. Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells from a familial hypercholesterolemia homozygote. Proc Natl Acad Sci USA 1976, 73(7):2434-2438.
38. Anderson R.G., Brown M.S., Goldstein J.L. Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts. Cell 1977, 10(3):351-364.
39. Ishibashi S., Herz J., Maeda N., Goldstein J.L., Brown M.S. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994, 91(10):4431-4435.
40. Liu J., Sukhova G.K., Yang J.T., Sun J., Ma L., Ren A., Xu W.H., Fu H., Dolganov G.M., Hu C., et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 2006, 184(2):302-311.
41. Li W., Kornmark L., Jonasson L., Forssell C., Yuan X.M. Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 2009, 202(1):92-102.